VENTURA, CALIF. (CN) - A woman whose husband was prescribed Solvay Pharmaceuticals' topical drug AndroGel as testosterone replacement therapy, claims her 5-year-old son's normal skin contact with his father caused the boy to suffer "accelerated skeletal maturation, precocious puberty, aggressive behavioral problems, advanced bone age, sexual frustration, disrupted normal sexual development and the possibility of decreased final adult height."
The plaintiffs claim Solvay knew or should have known of the complications, but failed to warn consumers of it, while aggressively pushing the drug.
They also sue Longs Drug Stores, in Ventura County Court. They are represented by Girardi & Keese of Los Angeles.
Subscribe to Closing Arguments
Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.
Additional Reads
-
Alaska, Hawaiian Airlines April 17, 2024 -
-
Contributor-Test-Post-2024-04-12 April 12, 2024 -
